logo

Sarcopenia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Sarcopenia Treatment Market is Segmented by Treatment Type (Protein Supplement, Vitamin B12 Supplement, Vitamin D & Calcium Supplement and Others), Distribution Channel and Geography

Home Industry Reports Healthcare Sarcopenia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (20 ...

Market Snapshot

Sarcopenia treatement market_Pic 1
Study Period:

2018 - 2026

Base Year:

2020

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

5.71 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Sarcopenia Treatment Market is expected to grow at a CAGR of 5.71% during the forecast period. The market is expected to grow due to the rising of the geriatric population, as with growing age the chance of muscle weakness gets increased. The risk of disability is 1.5 to 4.6 times higher in older adults with sarcopenia than older adults without sarcopenia. 

In accordance with the data from World Population Prospects: the 2019 Revision, by 2050, 1 in 6 people in the world will be over age 65 (16%), up from 1 in 11 in 2019 (9%) and by 2050, 1 in 4 persons living in Europe and Northern America could be aged 65 or over. In 2018, the persons aged 65 or above outnumbered children under five years of age globally. Therefore the number of persons aged 80 years or over is projected to triple, from 143 million in 2019 to 426 million in 2050. Hence with the growing aging population and increasing interest in preventive healthcare results in rising adoption of supplements is a major factor in boosting the demand for sarcopenia treatment.

Scope of the Report

As per the scope of the report, sarcopenia is a term used to describe the loss of muscle mass, strength, and function that is associated with ageing. Currently, there are no FDA-approved medications for the treatment of sarcopenia. The effects of exercise and nutritional supplementation on patients with sarcopenia have been examined in numerous studies. 

Treatment Type
Protein Supplement
Vitamin B12 Supplement
Vitamin D & Calcium Supplement
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Protein Supplement is Anticipated to Show Considerable Growth During the Forecast Period

Nutrition supplementation along with exercise is an effective strategy to decrease all the macronutrients can be used for energy production in human body, but only protein serves as a structural and functional compound in all organs and cells, which is why its demand is likely to increase in future. 

Proteins, especially rich in leucine, are the most effective branched-chain amino acid at stimulating muscle protein synthesis. Protein supplements help to retain the muscle mass muscle strength, and endurance. Recent evidence by Anne-Julie Tessier et al., supports a higher protein intake recommendation of 1.0–1.2 g/kg/day in healthy older adults; an evenly distributed mealtime protein intake or minimal protein per meal is considered to be beneficial. Hence all these factors are expected to drive the overall market growth.

Aging graph.png

To understand key trends, Download Sample Report

North America is Expected to Dominate the Sarcopenia Treatment Market

North America is expected to hold a dominant position in the sarcopenia treatment market, owing to presence of developed healthcare facilities and technological advancements that are likely to fuel growth of the sarcopenia treatment market during the forecast period.

As per the Population Reference Bureau, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group’s share of the total population will rise from 16% to 23%. About 45% of older adults in the United States are affected by sarcopenia, which is expected to increase as the population ages. In addition, there is a considerable economic burden of related healthcare expenditures for sarcopenia in the United States which is estimated to be USD 18.5 billion annually. Furthermore, the health awareness and active presence of major players are likely to drive the studied market growth in this region.

In addition, the rising population, increased research activities, and awareness in developing countries are the factors contributing to the growth of the sarcopenia treatment market in Asia region.

Picture4.png

To understand geography trends, Download Sample Report

Competitive Landscape

The key manufacturers in the sarcopenia treatment market have been focusing on novel marketing and sales strategies to increase their product penetration. Along with that, rising inclination towards online distribution channel have been playing a vital role. Few of the key market players in the studied market are GlaxoSmithKline plc, Eli Lilly and Company, Nestlé S.A., Sanofi S.A., Bayer AG among others.

Sarcopenia treatement market_Pic 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Geriatric Population

      2. 4.2.2 Malnutrition and Vitamin Deficiency in Developing Countries

    3. 4.3 Market Restraints

      1. 4.3.1 Non-availability of New Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Treatment Type

      1. 5.1.1 Protein Supplement

      2. 5.1.2 Vitamin B12 Supplement

      3. 5.1.3 Vitamin D & Calcium Supplement

      4. 5.1.4 Others

    2. 5.2 Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Retail Pharmacies

      3. 5.2.3 Online Pharmacies

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GlaxoSmithKline plc

      2. 6.1.2 Nestle Health Science

      3. 6.1.3 Sanofi S.A.

      4. 6.1.4 Bayer AG

      5. 6.1.5 Novartis AG

      6. 6.1.6 Cadila Healthcare Ltd

      7. 6.1.7 Eli Lilly and Company

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Sarcopenia Treatment Market market is studied from 2018 - 2026.

The Sarcopenia Treatment Market is growing at a CAGR of 5.71% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

  • Bayer AG
  • Zydus Cadila
  • GlaxoSmithKline plc
  • Nestle Health Science
  • Sanofi S.A.

Are the major companies operating in Sarcopenia Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!